AlphaMark Advisors’s Fresenius Medical Care FMS Stock Holding History

AlphaMark Advisors’s Portfolio FMS Stock Details FMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-100	Closed	-$4K	–	543
2020 Q2	$4K	Buy	100 +81	+426%	+$3.2K	﹤0.01%	446
2020 Q1	$1K	Buy	+19	New	+$706	﹤0.01%	514

Other funds holding FMS

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

TIM

Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TAM

Todd Asset Management Louisville, Kentucky $5.11B AUM 34.73% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

AlphaMark Advisors's FMS Position: Q3 2020 in Review

AlphaMark Advisors sold out of Fresenius Medical Care (FMS) in Q3 2020, closing a stake of 100 shares — an estimated $4K sold.

AlphaMark Advisors first reported a position in FMS in Q1 2020 and held it in 2 quarters. The position peaked at $4K in Q2 2020. 181 funds tracked by Wall St. Rank hold FMS as of Q3 2020.

AlphaMark Advisors reported no remaining Fresenius Medical Care position as of Q3 2020 after selling out during the quarter.
AlphaMark Advisors sold 100 Fresenius Medical Care shares in Q3 2020, an estimated $4K.
AlphaMark Advisors first reported a position in Fresenius Medical Care in Q1 2020 and held it in 2 quarters.
AlphaMark Advisors's Fresenius Medical Care position peaked at $4K in Q2 2020.
181 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q3 2020.

Based on AlphaMark Advisors's 13F filing for Q3 2020, filed 6 Nov 2020.